HuGE Literature Finder
Records
1
-
4
Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations. Cancer 2022 Sep . Ball Somedeb, Knepper Todd C, Deutsch Yehuda E, Samra Wassim, Watts Justin M, Bradley Terrence J, Chan Onyee, Hussaini Mohammad Omar, Zhang Ling, Sweet Kendra L, Kuykendall Andrew T, Talati Chetasi, Padron Eric, Komrokji Rami S, Lancet Jeffrey E, Sallman David |
[Immunohistochemical evaluation of BCL-2 expression in acute myeloid leukemia, myeloid sarcoma, and blastic plasmacytoid dendritic cell neoplasm]. [Rinsho ketsueki] The Japanese journal of clinical hematology 2021 1 61 (12): 1647-1653. Saika Wataru, Kawahara Masahiro, Tashiro Haruka, Teramoto Yukako, Nagai Shiho, Kumode Mina, Iwasa Masaki, Asai Ai, Fujishiro Aya, Nishimura Rie, Minamiguchi Hitoshi, Moritani Suzuko, Kito Katsuyuki, Andoh Aki |
Determination of CEBPA mutations by next generation sequencing in pediatric acute leukemia. Bratislavske lekarske listy 2018 119 (6): 366-372. Akin D F, Oner D A, Kurekci E, Akar |
Mutations of the epigenetics-modifying gene (DNMT3a, TET2, IDH1/2) at diagnosis may induce FLT3-ITD at relapse in de novo acute myeloid leukemia. Leukemia 2013 Apr 27 (5): 1044-52. Wakita S, Yamaguchi H, Omori I, Terada K, Ueda T, Manabe E, Kurosawa S, Iida S, Ibaraki T, Sato Y, Todoroki T, Hirakawa T, Ryotokuji T, Arai K, Kitano T, Mitamura Y, Kosaka F, Dan K, Inokuchi |
- Page last reviewed:Feb 1, 2023
- Page last updated:Mar 28, 2023
- Content source: